ENTITY
Innovent Biologics Inc

Innovent Biologics Inc (1801 HK)

382
Analysis
Health CareChina
Innovent Biologics, Inc. operates as a biopharmaceutical company. The Company develops, manufactures, and distributes monoclonal antibody drug candidates for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and other diseases. Innovent Biologics serves customers in China.
more
Company Presentation25 Aug 2021 06:00
Company Presentation29 Mar 2022 06:00
Company Presentation25 Aug 2022 06:00
Company Presentation28 Mar 2023 06:00
Company Presentation23 Aug 2023 06:00
x